Whole-Body In Vivo Monitoring of Inflammatory Diseases Exploiting Human Interleukin 6-Luciferase Transgenic Mice

REFERENCES

• Kobayashi E, Suzuki T, Yamamoto M. 2013. Roles nrf2 plays in myeloid cells and related disorders. Oxid Med Cell Longev 2013:529219.
   PubMed Web of Science ®Google Scholar
• Motohashi H, Yamamoto M. 2004. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 10:549–557. http://dx.doi.org/10.1016/j.molmed.2004.09.003.
   PubMed Web of Science ®Google Scholar
• Hirano T, Akira S, Taga T, Kishimoto T. 1990. Biological and clinical aspects of interleukin 6. Immunol Today 11:443–449. http://dx.doi.org/10.1016/0167-5699(90)90173-7.
   PubMedGoogle Scholar
• Akira S, Isshiki H, Nakajima T, Kinoshita S, Nishio Y, Natsuka S, Kishimoto T. 1992. Regulation of expression of the interleukin 6 gene: structure and function of the transcription factor NF-IL6. Ciba Found Symp 167:47–62.
   PubMedGoogle Scholar
• Kishimoto T. 2005. Interleukin-6: from basic science to medicine—40 years in immunology. Annu Rev Immunol 23:1–21. http://dx.doi.org/10.1146/annurev.immunol.23.021704.115806.
   PubMed Web of Science ®Google Scholar
• DaVeiga SP. 2012. Epidemiology of atopic dermatitis: a review. Allergy Asthma Proc 33:227–234. http://dx.doi.org/10.2500/aap.2012.33.3569.
   PubMed Web of Science ®Google Scholar
• Tauchi M, Hida A, Negishi T, Katsuoka F, Noda S, Mimura J, Hosoya T, Yanaka A, Aburatani H, Fujii-Kuriyama Y, Motohashi H, Yamamoto M. 2005. Constitutive expression of aryl hydrocarbon receptor in keratinocytes causes inflammatory skin lesions. Mol Cell Biol 25:9360–9368. http://dx.doi.org/10.1128/MCB.25.21.9360-9368.2005.
   PubMed Web of Science ®Google Scholar
• Mimura J, Yamashita K, Nakamura K, Morita M, Takagi TN, Nakao K, Ema M, Sogawa K, Yasuda M, Katsuki M, Fujii-Kuriyama Y. 1997. Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 2:645–654.
   PubMed Web of Science ®Google Scholar
• Mimura J, Fujii-Kuriyama Y. 2003. Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta 1619:263–268. http://dx.doi.org/10.1016/S0304-4165(02)00485-3.
   PubMed Web of Science ®Google Scholar
• Arruda LK, Sole D, Baena-Cagnani CE, Naspitz CK. 2005. Risk factors for asthma and atopy. Curr Opin Allergy Clin Immunol 5:153–159. http://dx.doi.org/10.1097/01.all.0000162308.89857.6c.
   PubMed Web of Science ®Google Scholar
• Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, Weiland SK, Williams H; Phase Three Study Group ISAAC. 2006. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368:733–743. http://dx.doi.org/10.1016/S0140-6736(06)69283-0.
   PubMed Web of Science ®Google Scholar
• Baxter AG. 2007. The origin and application of experimental autoimmune encephalomyelitis. Nat Rev Immunol 7:904–912. http://dx.doi.org/10.1038/nri2190.
   PubMed Web of Science ®Google Scholar
• Johnson DA, Amirahmadi S, Ward C, Fabry Z, Johnson JA. 2010. The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. Toxicol Sci 114:237–246. http://dx.doi.org/10.1093/toxsci/kfp274.
   PubMedGoogle Scholar
• Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, Nabeshima Y. 1997. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236:313–322. http://dx.doi.org/10.1006/bbrc.1997.6943.
   PubMed Web of Science ®Google Scholar
• Itoh K, Tong KI, Yamamoto M. 2004. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med 36:1208–1213. http://dx.doi.org/10.1016/j.freeradbiomed.2004.02.075.
   PubMed Web of Science ®Google Scholar
• Itoh K, Mimura J, Yamamoto M. 2010. Discovery of the negative regulator of Nrf2, Keap1: a historical overview. Antioxid Redox Signal 13:1665–1678. http://dx.doi.org/10.1089/ars.2010.3222.
   PubMed Web of Science ®Google Scholar
• Itoh K, Mochizuki M, Ishii Y, Ishii T, Shibata T, Kawamoto Y, Kelly V, Sekizawa K, Uchida K, Yamamoto M. 2004. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Δ12,14-prostaglandin J2. Mol Cell Biol 24:36–45. http://dx.doi.org/10.1128/MCB.24.1.36-45.2004.
   PubMed Web of Science ®Google Scholar
• Ishii Y, Itoh K, Morishima Y, Kimura T, Kiwamoto T, Iizuka T, Hegab AE, Hosoya T, Nomura A, Sakamoto T, Yamamoto M, Sekizawa K. 2005. Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. J Immunol 175:6968–6975. http://dx.doi.org/10.4049/jimmunol.175.10.6968.
   PubMed Web of Science ®Google Scholar
• Yoh K, Itoh K, Enomoto A, Hirayama A, Yamaguchi N, Kobayashi M, Morito N, Koyama A, Yamamoto M, Takahashi S. 2001. Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int 60:1343–1353. http://dx.doi.org/10.1046/j.1523-1755.2001.00939.x.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Moriguchi T, Ohneda K, Yamamoto M. 2009. Differential contribution of the Gata1 gene hematopoietic enhancer to erythroid differentiation. Mol Cell Biol 29:1163–1175. http://dx.doi.org/10.1128/MCB.01572-08.
   PubMedGoogle Scholar
• Takai J, Moriguchi T, Suzuki M, Yu L, Ohneda K, Yamamoto M. 2013. The Gata1 5′ region harbors distinct cis-regulatory modules that direct gene activation in erythroid cells and gene inactivation in HSCs. Blood 122:3450–3460. http://dx.doi.org/10.1182/blood-2013-01-476911.
   PubMedGoogle Scholar
• Suzuki M, Ohneda K, Hosoya-Ohmura S, Tsukamoto S, Ohneda O, Philipsen S, Yamamoto M. 2006. Real-time monitoring of stress erythropoiesis in vivo using Gata1 and beta-globin LCR luciferase transgenic mice. Blood 108:726–733. http://dx.doi.org/10.1182/blood-2005-10-4064.
   PubMedGoogle Scholar
• Miller SD, Karpus WJ, Davidson TS. 2010. Experimental autoimmune encephalomyelitis in the mouse. Curr Protoc Immunol 88:15.1.1–15.1.20. http://dx.doi.org/10.1002/0471142735.im1501s88.
   Google Scholar
• Zhang X, Goncalves R, Mosser DM. 2008. The isolation and characterization of murine macrophages. Curr Protoc Immunol 83:14.1.1–14.1.14. http://dx.doi.org/10.1002/0471142735.im1401s83.
   Google Scholar
• Yu L, Moriguchi T, Souma T, Takai J, Satoh H, Morito N, Engel JD, Yamamoto M. 2014. GATA2 regulates body water homeostasis through maintaining aquaporin 2 expression in renal collecting ducts. Mol Cell Biol 34:1929–1941. http://dx.doi.org/10.1128/MCB.01659-13.
   PubMedGoogle Scholar
• Erta M, Quintana A, Hidalgo J. 2012. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 8:1254–1266. http://dx.doi.org/10.7150/ijbs.4679.
   PubMed Web of Science ®Google Scholar
• Gauldie J, Richards C, Baumann H. 1992. IL6 and the acute phase reaction. Res Immunol 143:755–759. http://dx.doi.org/10.1016/0923-2494(92)80018-G.
   PubMedGoogle Scholar
• Michalopoulos GK. 2007. Liver regeneration. J Cell Physiol 213:286–300. http://dx.doi.org/10.1002/jcp.21172.
   PubMed Web of Science ®Google Scholar
• Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. 2004. New insights into atopic dermatitis. J Clin Invest 113:651–657. http://dx.doi.org/10.1172/JCI21060.
   PubMed Web of Science ®Google Scholar
• Thimmulappa RK, Lee H, Rangasamy T, Reddy SP, Yamamoto M, Kensler TW, Biswal S. 2006. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest 116:984–995. http://dx.doi.org/10.1172/JCI25790.
   PubMed Web of Science ®Google Scholar
• Ignowski JM, Schaffer DV. 2004. Kinetic analysis and modeling of firefly luciferase as a quantitative reporter gene in live mammalian cells. Biotechnol Bioeng 86:827–834. http://dx.doi.org/10.1002/bit.20059.
   PubMed Web of Science ®Google Scholar
• Samuel JM, Kelberman D, Smith AJ, Humphries SE, Woo P. 2008. Identification of a novel regulatory region in the interleukin-6 gene promoter. Cytokine 42:256–264. http://dx.doi.org/10.1016/j.cyto.2008.02.008.
   PubMed Web of Science ®Google Scholar